Category: Headlines in Dermatology

U.S. FDA OKs Quoin’s Second Netherton Syndrome Clinical Study

The U.S. Food and Drug Administration (FDA) has cleared a second Netherton Syndrome (NS) pivotal clinical study from Quoin Pharmaceuticals Ltd.